Fei Duan

Title: Fei Duan: Innovator in Cancer Immunotherapy

Introduction

Fei Duan is a notable inventor based in Farmington, Connecticut, recognized for his contributions to cancer treatment through innovative research. His work focuses on the identification of tumor-protective epitopes, which play a crucial role in personalized immunotherapy for cancer patients.

Latest Patents

Fei Duan holds a patent titled "Identification of tumor-protective epitopes for the treatment of cancers." This patent describes methods for identifying tumor-specific epitopes from the DNA of cancer tissues using advanced DNA sequencing and bioinformatics techniques. The identification of these epitopes is essential for developing pharmaceutical compositions that contain a limited number of tumor-specific peptides, which are suitable for personalized genomics-driven immunotherapy. A significant aspect of his patent is the introduction of the Differential Agretopic Index (DAI), which predicts the protective potential of immunization with specific epitopes against tumors. The patent also includes pharmaceutical compositions and methods of administration.

Career Highlights

Fei Duan is affiliated with the University of Connecticut, where he contributes to groundbreaking research in cancer immunotherapy. His work has the potential to transform treatment approaches for cancer patients by enabling personalized therapies that are tailored to individual tumor profiles.

Collaborations

Fei Duan has collaborated with esteemed colleagues such as Pramod K Srivastava and Ion Mandoiu, enhancing the impact of his research through shared expertise and innovative ideas.

Conclusion

Fei Duan's innovative work in identifying tumor-protective epitopes represents a significant advancement in cancer treatment, paving the way for personalized immunotherapy solutions. His contributions are vital in the ongoing fight against cancer, showcasing the importance of research and innovation in medical science.